Treating malignant solid epithelial tumor e.g. breast cancer, with combination of pre-mRNA splicing modulator and DNA-damaging agent, comprises carrying out treatment cyclically, first by administering pre-mRNA splicing modulator
2024-04-10
专利权人FEDERAL SCI & CLINICAL CENT PHYSICOCHEM (SCCL-Non-standard) ; SHENDER V O (SHEN-Individual)
申请日期2024-04-10
专利号RU2024109672-A
成果简介NOVELTY - Treating a malignant solid epithelial tumor in a mammal with a combination of a pre-mRNA splicing modulator and a DNA-damaging agent, comprises carrying out the treatment cyclically, first by administering a pre-mRNA splicing modulator to the mammal, then by exposing the mammal to a DNA-damaging agent, where the treatment cycle is repeated at least 4 times with a 1-2 day break between cycles. USE - The method is useful for treating a malignant solid epithelial tumor in a mammal with a combination of a pre-mRNA splicing modulator and a DNA-damaging agent, where the malignant solid epithelial tumor is breast cancer, pancreatic cancer, prostate cancer, colon or rectal cancer, lung cancer, stomach cancer, cervical cancer, endometrial cancer, ovarian cancer, or cholangiocarcinoma, and the mammal is a human. No biological data given. ADVANTAGE - None given.
IPC 分类号A61P-035/00 ; C12N-015/10
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/17257
专题中国科学院新疆生态与地理研究所
作者单位
1.FEDERAL SCI & CLINICAL CENT PHYSICOCHEM (SCCL-Non-standard)
2.SHENDER V O (SHEN-Individual)
推荐引用方式
GB/T 7714
SHENDER V O,ANUFRIEVA K S,ARAPIDI G P,et al. Treating malignant solid epithelial tumor e.g. breast cancer, with combination of pre-mRNA splicing modulator and DNA-damaging agent, comprises carrying out treatment cyclically, first by administering pre-mRNA splicing modulator. RU2024109672-A[P]. 2024.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。